Cargando…
Determinants of household catastrophic costs for drug sensitive tuberculosis patients in Kenya
BACKGROUND: Despite free diagnosis and treatment for tuberculosis (TB), the costs during treatment impose a significant financial burden on patients and their households. The study sought to identify the determinants for catastrophic costs among patients with drug-sensitive TB (DSTB) and their house...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256229/ https://www.ncbi.nlm.nih.gov/pubmed/34225790 http://dx.doi.org/10.1186/s40249-021-00879-4 |
_version_ | 1783718060176179200 |
---|---|
author | Kirubi, Beatrice Ong’ang’o, Jane Nguhiu, Peter Lönnroth, Knut Rono, Aiban Sidney-Annerstedt, Kristi |
author_facet | Kirubi, Beatrice Ong’ang’o, Jane Nguhiu, Peter Lönnroth, Knut Rono, Aiban Sidney-Annerstedt, Kristi |
author_sort | Kirubi, Beatrice |
collection | PubMed |
description | BACKGROUND: Despite free diagnosis and treatment for tuberculosis (TB), the costs during treatment impose a significant financial burden on patients and their households. The study sought to identify the determinants for catastrophic costs among patients with drug-sensitive TB (DSTB) and their households in Kenya. METHODS: The data was collected during the 2017 Kenya national patient cost survey from a nationally representative sample (n = 1071). Treatment related costs and productivity losses were estimated. Total costs exceeding 20% of household income were defined as catastrophic and used as the outcome. Multivariable Poisson regression analysis was performed to measure the association between selected individual, household and disease characteristics and occurrence of catastrophic costs. A deterministic sensitivity analysis was carried using different thresholds and the significant predictors were explored. RESULTS: The proportion of catastrophic costs among DSTB patients was 27% (n = 294). Patients with catastrophic costs had higher median productivity losses, 39 h [interquartile range (IQR): 20–104], and total median costs of USD 567 (IQR: 299–1144). The incidence of catastrophic costs had a dose response with household expenditure. The poorest quintile was 6.2 times [95% confidence intervals (CI): 4.0–9.7] more likely to incur catastrophic costs compared to the richest. The prevalence of catastrophic costs decreased with increasing household expenditure quintiles (proportion of catastrophic costs: 59.7%, 32.9%, 23.6%, 15.9%, and 9.5%) from the lowest quintile (Q1) to the highest quintile (Q5). Other determinants included hospitalization: prevalence ratio (PR) = 2.8 (95% CI: 1.8–4.5) and delayed treatment: PR = 1.5 (95% CI: 1.3–1.7). Protective factors included receiving care at a public health facility: PR = 0.8 (95% CI: 0.6–1.0), and a higher body mass index (BMI): PR = 0.97 (95% CI: 0.96–0.98). Pre TB expenditure, hospitalization and BMI were significant predictors in all sensitivity analysis scenarios. CONCLUSIONS: There are significant inequities in the occurrence of catastrophic costs. Social protection interventions in addition to existing medical and public health interventions are important to implement for patients most at risk of incurring catastrophic costs. GRAPHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40249-021-00879-4. |
format | Online Article Text |
id | pubmed-8256229 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-82562292021-07-06 Determinants of household catastrophic costs for drug sensitive tuberculosis patients in Kenya Kirubi, Beatrice Ong’ang’o, Jane Nguhiu, Peter Lönnroth, Knut Rono, Aiban Sidney-Annerstedt, Kristi Infect Dis Poverty Research Article BACKGROUND: Despite free diagnosis and treatment for tuberculosis (TB), the costs during treatment impose a significant financial burden on patients and their households. The study sought to identify the determinants for catastrophic costs among patients with drug-sensitive TB (DSTB) and their households in Kenya. METHODS: The data was collected during the 2017 Kenya national patient cost survey from a nationally representative sample (n = 1071). Treatment related costs and productivity losses were estimated. Total costs exceeding 20% of household income were defined as catastrophic and used as the outcome. Multivariable Poisson regression analysis was performed to measure the association between selected individual, household and disease characteristics and occurrence of catastrophic costs. A deterministic sensitivity analysis was carried using different thresholds and the significant predictors were explored. RESULTS: The proportion of catastrophic costs among DSTB patients was 27% (n = 294). Patients with catastrophic costs had higher median productivity losses, 39 h [interquartile range (IQR): 20–104], and total median costs of USD 567 (IQR: 299–1144). The incidence of catastrophic costs had a dose response with household expenditure. The poorest quintile was 6.2 times [95% confidence intervals (CI): 4.0–9.7] more likely to incur catastrophic costs compared to the richest. The prevalence of catastrophic costs decreased with increasing household expenditure quintiles (proportion of catastrophic costs: 59.7%, 32.9%, 23.6%, 15.9%, and 9.5%) from the lowest quintile (Q1) to the highest quintile (Q5). Other determinants included hospitalization: prevalence ratio (PR) = 2.8 (95% CI: 1.8–4.5) and delayed treatment: PR = 1.5 (95% CI: 1.3–1.7). Protective factors included receiving care at a public health facility: PR = 0.8 (95% CI: 0.6–1.0), and a higher body mass index (BMI): PR = 0.97 (95% CI: 0.96–0.98). Pre TB expenditure, hospitalization and BMI were significant predictors in all sensitivity analysis scenarios. CONCLUSIONS: There are significant inequities in the occurrence of catastrophic costs. Social protection interventions in addition to existing medical and public health interventions are important to implement for patients most at risk of incurring catastrophic costs. GRAPHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40249-021-00879-4. BioMed Central 2021-07-05 /pmc/articles/PMC8256229/ /pubmed/34225790 http://dx.doi.org/10.1186/s40249-021-00879-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Kirubi, Beatrice Ong’ang’o, Jane Nguhiu, Peter Lönnroth, Knut Rono, Aiban Sidney-Annerstedt, Kristi Determinants of household catastrophic costs for drug sensitive tuberculosis patients in Kenya |
title | Determinants of household catastrophic costs for drug sensitive tuberculosis patients in Kenya |
title_full | Determinants of household catastrophic costs for drug sensitive tuberculosis patients in Kenya |
title_fullStr | Determinants of household catastrophic costs for drug sensitive tuberculosis patients in Kenya |
title_full_unstemmed | Determinants of household catastrophic costs for drug sensitive tuberculosis patients in Kenya |
title_short | Determinants of household catastrophic costs for drug sensitive tuberculosis patients in Kenya |
title_sort | determinants of household catastrophic costs for drug sensitive tuberculosis patients in kenya |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256229/ https://www.ncbi.nlm.nih.gov/pubmed/34225790 http://dx.doi.org/10.1186/s40249-021-00879-4 |
work_keys_str_mv | AT kirubibeatrice determinantsofhouseholdcatastrophiccostsfordrugsensitivetuberculosispatientsinkenya AT ongangojane determinantsofhouseholdcatastrophiccostsfordrugsensitivetuberculosispatientsinkenya AT nguhiupeter determinantsofhouseholdcatastrophiccostsfordrugsensitivetuberculosispatientsinkenya AT lonnrothknut determinantsofhouseholdcatastrophiccostsfordrugsensitivetuberculosispatientsinkenya AT ronoaiban determinantsofhouseholdcatastrophiccostsfordrugsensitivetuberculosispatientsinkenya AT sidneyannerstedtkristi determinantsofhouseholdcatastrophiccostsfordrugsensitivetuberculosispatientsinkenya |